CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout
← All indications

Trichuriasis

Infection with nematodes of the genus TRICHURIS, formerly called Trichocephalus.

Drugs by status

Approved for this indication (1)

  • mebendazole

Phase 4 trials (4)

  • albendazole
  • ivermectin
  • levamisole
  • moxidectin

Phase 3 trials (1)

  • emodepside

Phase 2 trials (2)

  • oxfendazole
  • oxantel

Organizations

Organization Involved with Phase 4 Indications (5)

  • University of London
  • Natural History Museum, United Kingdom
  • VLIR Institutional University Collaboration Programme
  • Ghent University
  • Government of Tanzania

Organization Involved with Phase 3 Indications (3)

  • University of Basel
  • Government of Laos
  • Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS)

Organization Involved with Phase 2 Indications (5)

  • Johns Hopkins University
  • Universidad Nacional de Salta
  • Cayetano Heredia University
  • Oxfendazole Development Group
  • University of Milano Bicocca

Organization Involved with Other Experimental Indications (3)

  • Universidad del Valle de Guatemala
  • MERTU/CDC-Universite de Valle de Guatemala
  • Centers for Disease Control and Prevention (CDC)

ICD-10 crosswalk

  • B79 — Trichuriasis

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.